5/22
12:34 pm
vrpx
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) had its "hold" rating re-affirmed by analysts at Maxim Group.
Report
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) had its "hold" rating re-affirmed by analysts at Maxim Group.
5/22
11:45 am
vrpx
Rating for VRPX
Low
Report
Rating for VRPX